Moody Aldrich Partners’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-51,157
| Closed | -$1.93M | – | 194 |
|
|
2025
Q1 | $1.93M | Sell |
51,157
-1,529
| -3% | -$57.7K | 0.4% | 87 |
|
|
2024
Q4 | $4.31M | Sell |
52,686
-1,483
| -3% | -$121K | 0.8% | 57 |
|
|
2024
Q3 | $6.19M | Sell |
54,169
-46,117
| -46% | -$5.27M | 1.13% | 32 |
|
|
2024
Q2 | $7.57M | Sell |
100,286
-18,316
| -15% | -$1.38M | 1.48% | 8 |
|
|
2024
Q1 | $8.1M | Sell |
118,602
-29,325
| -20% | -$2M | 1.38% | 14 |
|
|
2023
Q4 | $9.29M | Buy |
147,927
+7,757
| +6% | +$487K | 1.67% | 5 |
|
|
2023
Q3 | $7.15M | Buy |
140,170
+115,505
| +468% | +$5.89M | 1.35% | 19 |
|
|
2023
Q2 | $1.23M | Buy |
+24,665
| New | +$1.23M | 0.24% | 111 |
|